BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30882922)

  • 21. Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma.
    Liu Y; Liu Q; Wang Z; Chen M; Chen Y; Li X; Huang D; Fan S; Xiong W; Li G; Zhang W
    J Clin Lab Anal; 2020 Aug; 34(8):e23298. PubMed ID: 32697404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma.
    Liu X; Chen S; Tu J; Cai W; Xu Q
    Int J Mol Med; 2016 Mar; 37(3):825-35. PubMed ID: 26846697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
    Zhong JT; Wang HJ; Yu J; Zhang JH; Wang SF; Yang X; Su W
    Cancer Biomark; 2017; 19(2):213-220. PubMed ID: 28269757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of SDF-1α/CXCR4 signaling pathway in clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
    Li YL; Li YF; Li HF; Lv HQ; Sun DZ
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28559386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma.
    Zheng J; Li J; Xu L; Xie G; Wen Q; Luo J; Li D; Huang D; Fan S
    PLoS One; 2014; 9(2):e89220. PubMed ID: 24551240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.
    Lu Y; Liang Y; Zheng X; Deng X; Huang W; Zhang G
    J Exp Clin Cancer Res; 2019 Feb; 38(1):82. PubMed ID: 30770775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
    Wang S; Fang W
    Histopathology; 2011 Jan; 58(2):217-24. PubMed ID: 21255068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix Metalloproteinase 14 Overexpression Is Correlated with the Progression and Poor Prognosis of Nasopharyngeal Carcinoma.
    Yan TH; Lin ZH; Jiang JH; Lu SW; Que HX; Chen MA; He XS; Que GB; Xiao JN; Chen YQ
    Arch Med Res; 2015 Apr; 46(3):186-92. PubMed ID: 25829357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma.
    Xu Y; Zheng Z; Gao Y; Duan S; Chen C; Rong J; Wang K; Yun M; Weng H; Ye S; Zhang J
    Sci Rep; 2017 Apr; 7(1):745. PubMed ID: 28389646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implication of neuropilin-1 upregulation in human nasopharyngeal carcinoma.
    Xu Y; Li P; Zhang X; Wang J; Gu D; Wang Y
    Diagn Pathol; 2013 Sep; 8():155. PubMed ID: 24053763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of quantitative parameters of magnetic resonance perfusion-weighted imaging with vascular endothelial growth factor, microvessel density and hypoxia-inducible factor-1α in nasopharyngeal carcinoma: Evaluation on radiosensitivity study.
    Hu Y; E H; Yu X; Li F; Zeng L; Lu Q; Xi X; Shen L
    Clin Otolaryngol; 2018 Apr; 43(2):425-433. PubMed ID: 28892580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-Inducible Factor-1α (HIF-1α) Expression on Endothelial Cells in Juvenile Nasopharyngeal Angiofibroma: A Review of 70 cases and Tissue Microarray Analysis.
    Song X; Yang C; Zhang H; Wang J; Sun X; Hu L; Liu Z; Wang D
    Ann Otol Rhinol Laryngol; 2018 Jun; 127(6):357-366. PubMed ID: 29717655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; He QM; Huang BJ; Sun Y; Xie D; Zeng J; Wang HY; Ma J
    Med Oncol; 2013 Mar; 30(1):360. PubMed ID: 23307239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A group of novel HIF-1α inhibitors, glyceollins, blocks HIF-1α synthesis and decreases its stability via inhibition of the PI3K/AKT/mTOR pathway and Hsp90 binding.
    Lee SH; Jee JG; Bae JS; Liu KH; Lee YM
    J Cell Physiol; 2015 Apr; 230(4):853-62. PubMed ID: 25204544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma.
    Li XM; Huang WG; Yi H; Cheng AL; Xiao ZQ
    J Cancer Res Clin Oncol; 2009 Dec; 135(12):1763-75. PubMed ID: 19529960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.
    Wang N; Dong CR; Jiang R; Tang C; Yang L; Jiang QF; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2014; 7(1):322-30. PubMed ID: 24427353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.